Stocks Tips For Today: Indian equity benchmarks gained amid investors optimism that the economy will rebound strongly from the world’s worst Covid-19 outbreak.
Sun Pharma
HDFC AMC, Sun Pharma, Wipro, Cipla, IndiGo
Equity benchmarks in Japan and South Korea were little changed as trading began, while Australian stocks declined. Futures indicated Hong Kong shares would nudge higher after sliding into a bear market. The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, traded 0.3 percent higher at 11,349.50 as of 7:20 a.m.
Gold Price Maintains Uptrend on Global Cues, Jewellers’ Buying
Gold Silver Reports (GSR) – In the national capital, gold of 99.9% and 99.5% purity advanced by ₹130 each to ₹30,970 and ₹30,820 per 10 grams, respectively. The precious metal had gained ₹40 in the last two days. Sovereign, however, remained unchanged at ₹24,700 per piece of eight grams.
Stocks To Watch: Bank Of Baroda, Cadila Healthcare, Sun Pharma, Tech Mahindra
Gold Silver Reports (GSR) – Stocks To Watch: Bank Of Baroda, Cadila Healthcare, Sun Pharma, Tech Mahindra — The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, fluctuated between gains and losses to trade at 10,512 as of 7:30 a.m. Asian stocks opened lower after the cancellation of the U.S.-North Korea summit, which sparked a move to safe-haven assets.
Idea Cellular Stock Rises After Loss Narrows In March Quarter
Gold Silver Reports (GSR) – Idea Cellular Stock Rises After Loss Narrows In March Quarter – Shares of the country’s third largest wireless carrier rose as much as 4.65 percent, the most in nearly four months, to Rs 72 after its loss narrowed in December-March quarter.
Stocks To Watch: ACC, Bharat Dynamics, Fortis, Sun Pharma
Gold Silver Reports (GSR) – Stocks To Watch: ACC, Bharat Dynamics, Fortis, Sun Pharma – The S&P BSE Sensex Index closed 0.2 percent lower at 34,331.68, while the NSE Nifty 50 Index closed at 10,526.20, down 0.2 percent. Indian equity benchmarks halted nine-day winning streak, the longest rally in over three years.
Sun Pharma Gains After Receiving FDA Approval For ILUMYA
Gold Silver Reports (GSR) -Sun Pharma Gains After Receiving FDA Approval For ILUMYA — Shares of the country’s largest drug maker rose as much as 3.3 percent, the most in a month, to Rs 521.
Stocks To Watch: Axis Bank, Dilip Buildcon, Coal India, Essar Steel, Sun Pharma
Gold Silver Reports (GSR) – Stocks To Watch: Axis Bank, Dilip Buildcon, Coal India, Essar Steel, Sun Pharma — Indian equity benchmarks rose for second day in a row led by HDFC twins, Larsen & Toubro and Bharti Airtel ahead of U.S. Federal Reserve’s policy decision announced late on Wednesday.
Indian Equity Edged higher led by Vedanta, Mahindra & Mahindra, Bharti Airtel and Sun Pharma
Indian Equity Edged higher led by Vedanta, Mahindra & Mahindra, Bharti Airtel and Sun Pharma. — Indian equity benchmarks edged higher led by Vedanta, Mahindra & Mahindra, Bharti Airtel and Sun Pharma. However, the gains were capped as oil marketing companies — Indian Oil, Hindustan Petroleum and Bharat Petroleum were among the losers.
Sensex closes 276 points up, Nifty rises, Tata Steel, Sun Pharma top gainers
Gold Silver Reports — Sensex closes 276 points up, Nifty rises, Tata Steel, Sun Pharma top gainers — Market brimmed with confidence on Tuesday as the Sensex breached the 32,000 mark again by climbing 276 points to bring up a nearly one-month closing high, with the focus clearly on key macroeconomic data. The broader NSE Nifty scaled a high of 10,097.55 before closing up 87 points,or 0.87%, at 10,093.05, the highest closing since 1 August when it settled at 10,114.65.